DK158308C - Fremgangsmaade til stereospecifik fremstilling af 1-fenyl-2-(imidazol-1-yl)-aetanonoximer, der eventuelt er halogensubstitueret paa fenylringen og eventuelt substitueret paa imidazolringen - Google Patents

Fremgangsmaade til stereospecifik fremstilling af 1-fenyl-2-(imidazol-1-yl)-aetanonoximer, der eventuelt er halogensubstitueret paa fenylringen og eventuelt substitueret paa imidazolringen

Info

Publication number
DK158308C
DK158308C DK209679A DK209679A DK158308C DK 158308 C DK158308 C DK 158308C DK 209679 A DK209679 A DK 209679A DK 209679 A DK209679 A DK 209679A DK 158308 C DK158308 C DK 158308C
Authority
DK
Denmark
Prior art keywords
substituted
phenyling
ethanonoximes
imidazol
imidazole
Prior art date
Application number
DK209679A
Other languages
English (en)
Other versions
DK158308B (da
DK209679A (da
Inventor
Georg Mixich
Kurt Thiele
Original Assignee
Siegfried Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Siegfried Ag filed Critical Siegfried Ag
Publication of DK209679A publication Critical patent/DK209679A/da
Publication of DK158308B publication Critical patent/DK158308B/da
Application granted granted Critical
Publication of DK158308C publication Critical patent/DK158308C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK209679A 1978-05-24 1979-05-22 Fremgangsmaade til stereospecifik fremstilling af 1-fenyl-2-(imidazol-1-yl)-aetanonoximer, der eventuelt er halogensubstitueret paa fenylringen og eventuelt substitueret paa imidazolringen DK158308C (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CH565378 1978-05-24
CH565378 1978-05-24
CH16179 1979-01-09
CH16179 1979-01-09

Publications (3)

Publication Number Publication Date
DK209679A DK209679A (da) 1979-11-25
DK158308B DK158308B (da) 1990-04-30
DK158308C true DK158308C (da) 1990-10-08

Family

ID=25683702

Family Applications (2)

Application Number Title Priority Date Filing Date
DK209679A DK158308C (da) 1978-05-24 1979-05-22 Fremgangsmaade til stereospecifik fremstilling af 1-fenyl-2-(imidazol-1-yl)-aetanonoximer, der eventuelt er halogensubstitueret paa fenylringen og eventuelt substitueret paa imidazolringen
DK550888A DK158309C (da) 1978-05-24 1988-10-03 Fremgangsmaade til stereospecifik fremstilling af (z)-1-(4-klorfenyl)-2-(1h-imidazol-1-yl)-0-(4-klorbenzyl)-aetanonoxim eller (z)-1-(2,4-diklorfenyl)-2-(1h-imidazol-1-yl)-0-(2,4-diklorbenzyl)-aetanonoxim eller nitrat-additionssalte deraf

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK550888A DK158309C (da) 1978-05-24 1988-10-03 Fremgangsmaade til stereospecifik fremstilling af (z)-1-(4-klorfenyl)-2-(1h-imidazol-1-yl)-0-(4-klorbenzyl)-aetanonoxim eller (z)-1-(2,4-diklorfenyl)-2-(1h-imidazol-1-yl)-0-(2,4-diklorbenzyl)-aetanonoxim eller nitrat-additionssalte deraf

Country Status (18)

Country Link
US (2) US4443612A (da)
EP (1) EP0005794B1 (da)
AR (1) AR227629A1 (da)
AU (1) AU527171B2 (da)
CA (1) CA1120035A (da)
DE (1) DE2964445D1 (da)
DK (2) DK158308C (da)
ES (1) ES480826A1 (da)
FI (1) FI71311C (da)
GR (1) GR72261B (da)
IE (1) IE48786B1 (da)
IL (1) IL57364A (da)
IT (1) IT1120957B (da)
MC (1) MC1263A1 (da)
NO (1) NO152507C (da)
NZ (1) NZ190515A (da)
PH (1) PH19786A (da)
PT (1) PT69643A (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9113487D0 (en) * 1991-06-21 1991-08-07 Amersham Int Plc Agents for hypoxic cells
DE59708674D1 (de) * 1996-08-01 2002-12-12 Basf Ag Substituierte 3-phenylpyrazole
WO2024044232A1 (en) * 2022-08-23 2024-02-29 Emory University Compositions and methods for selective labeling of n-alkylated imidazole containing compounds and peptides

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2880238A (en) * 1958-04-23 1959-03-31 Dow Chemical Co 3, 3-dichloro-2-methylallyl oxime ethers
US3236889A (en) * 1963-12-26 1966-02-22 Dow Chemical Co o-2-propynyloxy benzaldehyde o-2-propynyloxime
GB1053429A (da) * 1964-11-26
SE371193B (da) * 1972-03-24 1974-11-11 Kabi Ab
DE2311177A1 (de) * 1973-03-07 1974-09-19 Hoechst Ag O-(dialkylaminoalkyl)-1-alkyl-5nitroimidazol-(2)-aldoxime und verfahren zu ihrer herstellung
GB1474316A (en) * 1975-02-12 1977-05-25 Seperic O-aminoalkyl oximes
CH617427A5 (da) * 1975-12-24 1980-05-30 Siegfried Ag

Also Published As

Publication number Publication date
PH19786A (en) 1986-07-02
IE791481L (en) 1979-11-24
PT69643A (de) 1979-06-01
EP0005794B1 (de) 1983-01-05
NO152507C (no) 1985-10-09
IE48786B1 (en) 1985-05-15
DK550888A (da) 1988-10-03
CA1120035A (en) 1982-03-16
GR72261B (da) 1983-10-10
IL57364A (en) 1984-05-31
IT1120957B (it) 1986-03-26
US4550175A (en) 1985-10-29
DK158309C (da) 1990-10-08
DE2964445D1 (en) 1983-02-10
AU527171B2 (en) 1983-02-17
DK158308B (da) 1990-04-30
FI71311C (fi) 1986-12-19
IT7968018A0 (it) 1979-05-14
DK158309B (da) 1990-04-30
NZ190515A (en) 1981-05-15
FI71311B (fi) 1986-09-09
ES480826A1 (es) 1980-08-16
IL57364A0 (en) 1979-09-30
AU4726779A (en) 1979-11-29
AR227629A1 (es) 1982-11-30
DK209679A (da) 1979-11-25
EP0005794A1 (de) 1979-12-12
DK550888D0 (da) 1988-10-03
MC1263A1 (fr) 1980-03-28
FI791493A7 (fi) 1979-11-25
US4443612A (en) 1984-04-17
NO152507B (no) 1985-07-01
NO791708L (no) 1979-11-27

Similar Documents

Publication Publication Date Title
DK158042C (da) Analogifremgangsmaade til fremstilling af 1-(1,3-dioxolan-2-ylmethyl)-1h-imidazol- og 1h-1,2,4-triazolderivater
DK197279A (da) Fremgangsmaade til fremstilling af imidazolderivater
DK159442C (da) Analogifremgangsmaade til fremstilling af 6,7-substitueret-4-ethyl-quinazoliner
DK161325C (da) Analogifremgangsmaade til fremstilling af imidazooe4,5-caa-pyridinderivater
DK281079A (da) Fremgangsmaade til fremstilling af 4,5-diaryl-2-nitroimidazoler
DK151260C (da) Analogifremgangsmaade til fremstilling af spiro-thienohydantoinderivater.
DK153552C (da) Analogifremgangsmaade til fremstilling af 1,8-naphthyridinderivater
ES514582A0 (es) Procedimiento para la obtencion de derivados de imidazol trisustituidos.
DK157551C (da) Analogifremgangsmaade til fremstilling af 1,3-dihydro-6-methyl-7-hydroxy-furo-(3,4-c)-pyridiner
FI800143A7 (fi) Menetelmä imidatsolijohdannaisten valmistamiseksi.
DK301180A (da) Fremgangsmaade til fremstilling af 5-substituerede 2,3-diarylthiophener
DK161147C (da) Analogifremgangsmaade til fremstilling af oe3haa-imidazo-oe5,1-daa-1,2,3,5-tetrazin-4-onderivater
NO154882C (no) Fremgangsmaate for fremstilling av 2-(2-(1,4-benzodioksanyl)) -2-imidazolin.
DK153844C (da) Analogifremgangsmaade til fremstilling af 1,2,3,5-tetrahydroimidazothienopyrimidin-2-oner
DK152132C (da) Analogifremgangsmaade til fremstilling af derivater af 5,6,7,7a-tetrahydro-4h-thienooe3,2-caapyridin-2-on
DK504979A (da) Fremgangsmaade til fremstilling af 1,2,4,5-tetraalkyl-4-arylpiperidiner
DK370781A (da) Fremgangsmaade til fremstilling af 3,4-bis-phenyl-1,2,4-triazoler
DK444479A (da) Fremgangsmaade til fremstilling af 3,4-dihydro-3-oxo-2-quinoxaliner
DK24079A (da) Fremgangsmaade til fremstilling af 1,2,4-triazol
DK40482A (da) Fremgangsmaade til fremstilling af 2-(2-(1,4-benzodioxanyl))-2-imidazolinderivater
FI821316A7 (fi) Menetelmä uusien substituoitujen imidatsoli- ja imidatsoliinijohdannaisten valmistamiseksi.
DK158308C (da) Fremgangsmaade til stereospecifik fremstilling af 1-fenyl-2-(imidazol-1-yl)-aetanonoximer, der eventuelt er halogensubstitueret paa fenylringen og eventuelt substitueret paa imidazolringen
DK558181A (da) Fremgangsmaade til fremstilling af 3,5-diamino-1,2,4-triazoler
DK178978A (da) Fremgangsmaade til fremstilling af 3,5-disubstituerede 1h-1,2,4-triazolderivater
DK156399C (da) Analogifremgangsmaade til fremstilling af spiro-quinolylhydantoin-derivater

Legal Events

Date Code Title Description
PUP Patent expired